Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ATOSATNM

Atossa Therapeutics, Inc.

ATOS · $2.60

56Fair

Actinium Pharmaceuticals, Inc.

ATNM · $1.52

78Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ATOS

56/100

ATNM

78/100

Quality

Is it a profitable, well-run business?

ATOS

2.0/10

ATNM

9.5/10

Growth

Is the company growing?

ATOS

0.0/10

ATNM

5.9/10

Valuation

Is the price reasonable? (higher = cheaper)

ATOS

7.5/10

ATNM

8.8/10

Risk

How risky are the shares? (higher = lower risk)

ATOS

3.4/10

ATNM

5.0/10

Momentum

Is the share price trending up?

ATOS

7.7/10

ATNM

8.4/10

Financial strength

Is the balance sheet healthy?

ATOS

5.0/10

ATNM

5.8/10

The balanced view

Model-generated

Atossa Therapeutics, Inc.

This company has a mixed profile, with supportive analyst views and a positive price trend, although its growth has been slow.

Leads on: no single area

Best feature: analysts broadly positive (Target upside: 1534.6%)

Watch out: growth is slow or negative (Net income growth (FY): -36.3%)

Actinium Pharmaceuticals, Inc.

This company scores well across most areas, with supportive analyst views and strong profitability.

Leads on: quality, growth, valuation, risk, momentum, financial strength

Best feature: analysts broadly positive (Analyst buy share: 100%)

Watch out: weakest area: risk profile (Price volatility (1Y, annualised): 72%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.